Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiated Thyroid Carcinoma (DTC)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableUnknownNCT04858867
What this trial is testing

Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)

Who this might be right for
Differentiated Thyroid Cancer
Leiden University Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT02702388
What this trial is testing

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Who this might be right for
Thyroid Cancer
Eisai Inc. 241
Not applicableStudy completedNCT07229859
What this trial is testing

Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening

Who this might be right for
Differentiated Thyroid Cancer (DTC)Robotic Assistance
Ruijin Hospital 332
Not applicableStudy completedNCT02764554
What this trial is testing

Post-Marketing Surveillance of Lenvima in Korean Patients

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)
Eisai Korea Inc. 132
Not applicableEnded earlyNCT02947399
What this trial is testing

Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 16
Not applicableNot Yet RecruitingNCT07812779
What this trial is testing

Thyroid Health Outcomes Registry for Surgery

Who this might be right for
Thyroid DiseasesThyroid NeoplasmsThyroid Cancer+9 more
Pirogov Russian National Research Medical University 3,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193186
What this trial is testing

Anlotinib and Benmelstobart in DTC

Who this might be right for
Thyroid Cancer
Fudan University 23
Large-scale testing (Phase 3)Study completedNCT04964284
What this trial is testing

RhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 390
Not applicableLooking for participantsNCT05024929
What this trial is testing

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Who this might be right for
Papillary Thyroid CancerPediatric CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia 32
Large-scale testing (Phase 3)Looking for participantsNCT06558981
What this trial is testing

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Who this might be right for
Thyroid Cancer
Fudan University 124
Testing effectiveness (Phase 2)UnknownNCT02041260
What this trial is testing

A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting

Who this might be right for
Differentiated Thyroid Cancer (DTC)Poorly Differentiated Thyroid Cancer
Thomas Jefferson University 43
Testing effectiveness (Phase 2)Study completedNCT02614495
What this trial is testing

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Hutchison Medipharma Limited 66
Large-scale testing (Phase 3)Not Yet RecruitingNCT07239674
What this trial is testing

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

Who this might be right for
Intermediate-to-High Risk Differentiated Thyroid Cancer
West China Hospital 646
Very early researchLooking for participantsNCT06898437
What this trial is testing

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Not applicableStudy completedNCT03239769
What this trial is testing

Compare the Aesthetic Effect of Different Thyroidectomies

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)
Peking University Cancer Hospital & Institute 120
Testing effectiveness (Phase 2)Study completedNCT02973997
What this trial is testing

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Who this might be right for
Columnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more
Academic and Community Cancer Research United 57
Not applicableNot Yet RecruitingNCT07770074
What this trial is testing

A Real-World Study of Second-line Therapies Among Radioiodine-refractory Differentiated Thyroid Cancer (RAI-R DTC) Patients

Who this might be right for
Radioiodine-refractory Differentiated Thyroid Cancer
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848920
What this trial is testing

Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)Neoadjuvant Therapy
Zhejiang University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06359847
What this trial is testing

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited 60
Not applicableActive Not RecruitingNCT02185560
What this trial is testing

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib

Who this might be right for
Thyroid Carcinoma
Bayer 453
Next Page